Phase I open-label, parallel-group clinical study in healthy term pregnant females to compare efficacy of oxytocin administration on postpartum uterine contractility.

Trial Profile

Phase I open-label, parallel-group clinical study in healthy term pregnant females to compare efficacy of oxytocin administration on postpartum uterine contractility.

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 29 Sep 2016

At a glance

  • Drugs Oxytocin (Primary) ; Oxytocin (Primary)
  • Indications Postpartum haemorrhage
  • Focus Pharmacodynamics
  • Sponsors Oxytone Bioscience
  • Most Recent Events

    • 29 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top